Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis, International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.4, pp.923-929, 1999. ,
DOI : 10.1016/S0360-3016(99)00284-9
Chimiothérapie des gliomes diffus de bas grade, Lettre du Neurologue, pp.118-120, 2008. ,
Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas, Journal of Clinical Oncology, vol.18, issue.3, pp.636-681, 2000. ,
DOI : 10.1200/JCO.2000.18.3.636
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas, Acta Neuropathologica, vol.108, issue.1, pp.44-56, 2004. ,
DOI : 10.1007/s00401-004-0861-z
Oligodendroglioma: clinical study and survival analysis correlated with chromosomal anomalies, Neurosurgical Focus, vol.61, issue.5, p.15, 2005. ,
DOI : 10.1016/S0360-3016(02)03053-5
Ancillary fish analysis for 1p and 19q status preliminary observations in 287 gliomas and oligodendroglioma mimics, Frontiers in Bioscience, vol.8, issue.1, pp.1-9, 2003. ,
DOI : 10.2741/896
Classification anatomo-pathologique des gliomes, Lettre du neurologue n°1, 2007. ,
Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas, Acta Neuropathologica, vol.103, issue.3, pp.267-275, 2002. ,
DOI : 10.1007/s004010100464
Population-Based Studies on Incidence, Survival Rates, and Genetic Alterations in Astrocytic and Oligodendroglial Gliomas, Journal of Neuropathology & Experimental Neurology, vol.10, issue.6, pp.479-489, 2005. ,
DOI : 10.1093/carcin/16.6.1277
Impact pronostic des mutations IDH1 et IDH2 dans les gliomes de bas grade, Résumé JNLF, 2011. ,
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2, Neurology, vol.74, issue.23, pp.1886-1890, 2010. ,
DOI : 10.1212/WNL.0b013e3181e1cf3a
Sofortige postoperative Strahlentherapie oder abwartende Haltung bei der Behandlung niedrigmaligner Gliome im Erwachsenenalter?, Strahlentherapie und Onkologie, vol.180, issue.7, pp.408-418, 2004. ,
DOI : 10.1007/s00066-004-1221-6
Guide pratique des médicaments-Dorosz : lomustine, 2010. ,
Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas, Neuro-Oncology, vol.24, issue.18, pp.1078-1082, 2010. ,
DOI : 10.1200/JCO.2005.04.6078
Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study, The Lancet, vol.360, issue.9343, pp.1361-68, 2002. ,
DOI : 10.1016/S0140-6736(02)11398-5
Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma, pp.69-75, 1998. ,
Retrospective analysis of treatment outcome in 315 patients with oligodendroglial brain tumors, BMC Neurology, vol.31, issue.1, p.33, 2009. ,
DOI : 10.1053/j.seminoncol.2004.07.006
Effets ?? long terme de la chimioth??rapie chez 7 patients pr??sentant un gliome de bas grade symptomatique, Revue Neurologique, vol.162, issue.11, pp.1069-75, 2006. ,
DOI : 10.1016/S0035-3787(06)75119-0
Low-grade oligodendroglioma responds to chemotherapy, Neurology, vol.46, issue.1, 1996. ,
DOI : 10.1212/WNL.46.1.203
Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine, Cancer, vol.52, issue.4, pp.802-809, 2005. ,
DOI : 10.1016/S0167-8140(96)91782-X
Phase II Trial of Procarbazine, Lomustine, and Vincristine as Initial Therapy for Patients With Low-Grade Oligodendroglioma or Oligoastrocytoma: Efficacy and Associations With Chromosomal Abnormalities, Journal of Clinical Oncology, vol.21, issue.2, pp.251-255 ,
DOI : 10.1200/JCO.2003.06.023
(s. d.) Common Terminology Criteria for Adverse Events (CTCAE) EVS - National Institutes of Health ,
Successful chemotherapy for newly diagnosed aggressive oligodendroglioma, Annals of Neurology, vol.59, issue.5, pp.573-574, 1990. ,
DOI : 10.1002/ana.410270519
Chemotherapy for low-grade oligodendroglioma?, 1994. ,
PCV Chemotherapy for Recurrent Oligodendrogliomas and Oligoastrocytomas, Neurosurgery, vol.68, issue.5, pp.1066-1073, 1998. ,
DOI : 10.3171/jns.1988.68.5.0684
Response rate and prognostics factors of recurrent oligodendroglioma treated with procarbazine, CCNU and vincristine chemotherapy, Neurooncology group, vol.51, issue.53, pp.1140-1145, 1998. ,
A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors, Journal of Neurology, vol.247, issue.4, pp.297-302, 2000. ,
DOI : 10.1007/s004150050587
Neoadjuvant chemotherapy for symptomatic non operable grade II fibrillary astrocytoma in adults, Revue Neuro, issue.160, pp.533-537, 2004. ,
Oligodendroglial tumor chemotherapy using "decreased-dose-intensity, 2006. ,
DOI : 10.1212/01.wnl.0000194211.68164.a0
Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy, European Journal of Neurology, vol.63, issue.4, pp.391-399, 2007. ,
DOI : 10.1002/cncr.20042
La qualité de vie en établissement d'hébergement pour personnes âgées dépendantes (Ehpad) Consulté le 22 Juin 2013 sur http Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow, Eur Arch Psychiatry Clin Neurosci, vol.256, issue.58, pp.516-521, 1990. ,
Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma, Journal of Clinical Oncology, vol.28, issue.30, pp.4601-4609, 2010. ,
DOI : 10.1200/JCO.2009.27.1932
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide, Journal of Clinical Oncology, vol.27, issue.35, pp.275874-80, 2009. ,
DOI : 10.1200/JCO.2009.23.6497
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors, Neuro-Oncology, vol.74, issue.23, pp.649-59, 2011. ,
DOI : 10.1212/WNL.0b013e3181e1cf3a
Quality of life in low-grade glioma patients receiving temozolomide, Neuro-Oncology, vol.11, issue.1, 2009. ,
DOI : 10.1023/A:1023900802254
Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up, The Lancet Neurology, vol.8, issue.9, pp.810-828, 2009. ,
DOI : 10.1016/S1474-4422(09)70204-2
Gliomes de bas grade et plasticit?? c??r??brale, m??decine/sciences, vol.22, issue.4, pp.389-394, 2006. ,
DOI : 10.1051/medsci/2006224389
URL : http://www.medecinesciences.org/articles/medsci/pdf/2006/05/medsci2006224p389.pdf